Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic‐progressive demyelinating disease

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The FASEB Journal

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1096/fj.01-0994fjePMID 12154009
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor.

  2001cited by this paper
• Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis.

  2000cited by this paper
• Acceleration in the Rate of CNS Remyelination in Lysolecithin-Induced Demyelination

  1998cited by this paper
• A Comparison of Three Methods for Production of Human Hybridomas Secreting Autoantibodies

  1998cited by this paper
• Effects of Transforming Growth Factor‐β and Platelet‐Derived Growth Factor on Oligodendrocyte Precursors: Insights Gained from a Neuronal Cell Line

  1997cited by this paper
• Successful treatment of established relapsing experimental autoimmune encephalomyelitis in mice with a monoclonal natural autoantibody.

  1997cited by this paper
• Effects of transforming growth factor-beta and platelet-derived growth factor on oligodendrocyte precursors: insights gained from a neuronal cell line.

  1997cited by this paper
• Generation of a high‐producing clone of a humanized anti‐B‐cell lymphoma monoclonal antibody (hLL2)

  1997cited by this paper
• A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes.

  1995cited by this paper
• Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis

  1994cited by this paper
• Proliferation and differentiation of O4+ oligodendrocytes in postnatal rat cerebellum: Analysis in unfixed tissue slices using anti‐glycolipid antibodies

  1992cited by this paper
• Nucleotide sequences of the cDNAs encoding the V-regions of H- and L-chains of a human monoclonal antibody with broad reactivity to malignant tumor cells.

  1989cited by this paper
• Molecular cloning of a human immunoglobulin lambda chain variable sequence.

  1984cited by this paper
• A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody.

  1984cited by this paper
• Isolation and expression of an altered mouse dihydrofolate reductase cDNA.

  1983cited by this paper

• DNA aptamers that modulate biological activity of model neurons

  2024cites this paper
• Frequency of an intrathecal IgM synthesis and MRZ reaction in children with MS.

  2024cites this paper
• A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse

  2022cites this paper
• The Antibody Dependant Neurite Outgrowth Modulation Response Involvement in Spinal Cord Injury

  2022cites this paper
• Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials

  2021cites this paper
• Natural Autoantibodies in Health and Disease

  2021cites this paper
• Structure, Function, and Therapeutic Use of IgM Antibodies

  2020cites this paper
• Human Monoclonal Antibodies: Methods and Protocols

  2019cites this paper
• Significance of Autoantibodies

  2019cites this paper
• The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination.

  2018cites this paper
• Surface Plasmon Resonance Sensing on Naturally Derived Membranes: A Remyelination-Promoting Human Antibody Binds Myelin with Extraordinary Affinity.

  2018cites this paper
• Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia

  2018cites this paper
• IgM Natural Autoantibodies in Physiology and the Treatment of Disease.

  2018cites this paper
• Human Remyelination Promoting Antibody Stimulates Astrocytes Proliferation Through Modulation of the Sphingolipid Rheostat in Primary Rat Mixed Glial Cultures

  2018cites this paper
• A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next?

  2018cites this paper
• A natural human monoclonal antibody protects from axonal injury in different CNS degenerative disease models

  2018cites this paper
• A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis

  2017cites this paper
• Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.

  2017cites this paper
• Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis

  2017cites this paper
• Timing of Future Remyelination Therapies and Their Potential to Stop Multiple Sclerosis Progression.

  2017cites this paper
• Recruitment of endogenous CNS stem cells for regeneration in demyelinating disease.

  2017cites this paper
• Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis

  2016cites this paper
• Neuroprotective therapies for multiple sclerosis and other demyelinating diseases

  2016cites this paper
• Progressive multiple sclerosis: from pathogenic mechanisms to treatment.

  2016cites this paper
• A monoclonal natural human IgM protects axons in the absence of remyelination

  2016cites this paper
• Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis

  2016cites this paper
• Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis.

  2016cites this paper
• Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis

  2016cites this paper
• Lipid rafts and their possible involvements in neuroimmunological disorders.

  2015cites this paper
• The Mechanism of Suppression By a Protective Peptide in a Mouse Model of Multiple Sclerosis

  2015cites this paper
• Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases.

  2015cites this paper
• Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease

  2015cites this paper
• A natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis

  2015cites this paper
• Applications of SPR for the characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseases

  2014cites this paper
• Using magnetic resonance imaging in animal models to guide drug development in multiple sclerosis

  2014cites this paper
• Polyclonal and monoclonal antibodies in clinic.

  2014cites this paper
• Remyelination in Multiple Sclerosis – How Close are We?

  2014cites this paper
• Promoting Remyelination in Multiple Sclerosis—Recent Advances

  2013cites this paper
• Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire

  2013cites this paper
• Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination

  2013cites this paper
• A patterned recombinant human IgM guides neurite outgrowth of CNS neurons

  2013cites this paper
• The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment

  2013cites this paper
• Naturally occurring antibodies as therapeutics for neurologic disease: can human monoclonal IgMs replace the limited resource IVIG?

  2012cites this paper
• Pathogenic and physiological autoantibodies in the central nervous system

  2012cites this paper
• Remyelination Induced by a DNA Aptamer in a Mouse Model of Multiple Sclerosis

  2012cites this paper
• Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.

  2012cites this paper
• Need for a paradigm shift in therapeutic approaches to CNS injury

  2012cites this paper
• Evidence for the Role of B Cells and Immunoglobulins in the Pathogenesis of Multiple Sclerosis

  2011cites this paper
• Role of γδ T cells in antibody production and recovery from SFV demyelinating disease.

  2011cites this paper
• Anticorps humains et leurs utilisations diagnostiques et thérapeutiques dans le traitement de troubles neurologiques

  2011cites this paper
• Method of Identifying Natural Antibodies for Remyelination

  2010cites this paper
• University of Minnesota - Molecular and Cellular Therapeutics (MCT)

  2009cites this paper
• Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?

  2009cites this paper
• Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies.

  2009cites this paper
• Invited Article: Human natural autoantibodies in the treatment of neurologic disease

  2009cites this paper
• Neuroprotection and neuroregeneration in multiple sclerosis

  2008cites this paper
• Boosting controlled autoimmunity: a new therapeutic target for CNS disorders

  2008cites this paper
• Review: New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins

  2008cites this paper
• Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease

  2008cites this paper
• A recombinant human IgM promotes myelin repair after a single, very low dose

  2007cites this paper
• Effectors of Demyelination and Remyelination in the CNS: Implications for Multiple Sclerosis

  2007cites this paper
• Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1beta.

  2006cites this paper
• Immunomodulation using the recombinant monoclonal human B7‐DC cross‐linking antibody rHIgM12

  2006cites this paper
• Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosis.

  2006cites this paper
• Monoclonal antibodies to distinct regions of human myelin proteolipid protein simultaneously recognize central nervous system myelin and neurons of many vertebrate species

  2006influential citation
• Promoting repair in multiple sclerosis: problems and prospects

  2005cites this paper
• Spontaneous remyelination following prolonged inhibition of alpha4 integrin in chronic EAE.

  2005cites this paper
• The Role of Astrocytes, Oligodendrocytes, Microglia and Endothelial Cells in TMEV Infection

  2005cites this paper
• Remyelination as Neuroprotection

  2005cites this paper
• Exacerbation of Motor Neuron Disease by Chronic Stimulation of Innate Immunity in a Mouse Model of Amyotrophic Lateral Sclerosis

  2004cites this paper
• Antibody-mediated remyelination operates through mechanism independent of immunomodulation.

  2004cites this paper
• A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2‐weighted spinal cord MRI in a virus‐induced murine model of MS

  2004cites this paper
• Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody.

  2004cites this paper
• The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

  2004cites this paper
• Neuron‐Binding Human Monoclonal Antibodies Support Central Nervous System Neurite Extension

  2004cites this paper
• Remyelinating and neuroprotective treatments in multiple sclerosis

  2004cites this paper
• Human Monoclonal IgM Antibody Promotes CNS Myelin Repair Independent of Fc Function

  2003cites this paper
• Recombinant antibody fragments as autoantibody antagonists

  2003cites this paper
• Multiple paths towards repair in multiple sclerosis.

  2003cites this paper
• Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders.

  2003cites this paper